Explore

Capbase

Crosslink Therapeutics Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Pharmaceuticals

$5.5MUncited—Raised (recorded)

UndisclosedUncited—Last valuation

Crosslink Therapeutics Inc. filed a Form D notice of exempt offering with the SEC.

1 round

1 round recorded · latest Private placement (Form D), Oct 2026 · $5.5M recorded

No investors recorded yet for Crosslink Therapeutics Inc..

Leadership

Ronald D. Seidel, IIIExecutive OfficerSince 2026Uncited—

Andrew KingDirectorSince 2026Uncited—

Crosslink Therapeutics Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Crosslink Therapeutics Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.